Roche files Avastin in European Union for lung cancer
Swiss drugmaker Roche Holding AG said Tuesday it has filed its top-selling drug Avastin to Europe’s medical regulator, for approval for use as a treatment for the most common form of lung cancer.
This entry was posted on Thursday, August 10th, 2006 at 10:19 am and is filed under Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.